Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Orchard Therapeutics plc | ortx-ex322_6.htm |
| EX-32.1 - EX-32.1 - Orchard Therapeutics plc | ortx-ex321_7.htm |
| EX-31.2 - EX-31.2 - Orchard Therapeutics plc | ortx-ex312_8.htm |
| EX-31.1 - EX-31.1 - Orchard Therapeutics plc | ortx-ex311_9.htm |
| EX-23.1 - EX-23.1 - Orchard Therapeutics plc | ortx-ex231_425.htm |
| EX-21.1 - EX-21.1 - Orchard Therapeutics plc | ortx-ex211_419.htm |
| EX-10.16 - EX-10.16 - Orchard Therapeutics plc | ortx-ex1016_421.htm |
| EX-10.15 - EX-10.15 - Orchard Therapeutics plc | ortx-ex1015_424.htm |
| EX-10.14 - EX-10.14 - Orchard Therapeutics plc | ortx-ex1014_423.htm |
| EX-10.13 - EX-10.13 - Orchard Therapeutics plc | ortx-ex1013_420.htm |
| EX-4.4 - EX-4.4 - Orchard Therapeutics plc | ortx-ex44_422.htm |
| 10-K - 10-K - Orchard Therapeutics plc | ortx-10k_20191231.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-230432 and 333-228067) of Orchard Therapeutics plc of our report dated March 22, 2019 relating to the financial statements, which appears in this Form 10-K.
|
/s/ PricewaterhouseCoopers LLP |
|
Reading, United Kingdom |
|
February 27, 2020 |